Roche Holdings AG Basel ADR Common Stock (RHHBY) Stock: What Does the Chart Say Friday?

Overall market sentiment has been down on Roche Holdings AG Basel ADR Common Stock (RHHBY) stock lately. RHHBY receives a Bearish rating from InvestorsObserver Stock Sentiment Indicator.

Roche Holdings AG Basel ADR Common Stock has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on RHHBY!

See Full RHHBY Report

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down. InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With RHHBY Stock Today?

Roche Holdings AG Basel ADR Common Stock (RHHBY) stock is trading at $31.30 as of 12:31 PM on Friday, Mar 22, a drop of -$0.02, or -0.06% from the previous closing price of $31.32. Volume today is light. So far 1,329,217 shares have traded compared to average volume of 1,795,921 shares. The stock has traded between $31.30 and $31.61 so far today. To screen for more stocks like Roche Holdings AG Basel ADR Common Stock click here.

More About Roche Holdings AG Basel ADR Common Stock

Roche is a Swiss biopharmaceutical and diagnostic company. The firm's best-selling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales. Click Here to get the full Stock Report for Roche Holdings AG Basel ADR Common Stock stock.